Roots Analysis has announced theaddition of “Peptidesand Macrocycle Drug Discovery:Services and Platforms Market, 2020-2030” report to its list of offerings.
The report featuresan extensive study on the current market landscape and future of companiesoffering services for peptides and macrocycle drug discovery operations. Thestudy includes in-depth analyses, highlighting the capabilities of variousservice / technology providers engaged in this market. Amongst other elements,the report includes:
§ A detailed assessmentof the current market landscape of companies offering peptide and macrocycledrug discovery services
§ An insightfulgeographical benchmarking of the capabilities of companies of various sizes,highlighting the key focus areas, comparing their existing strengths bothwithin and beyond their respective peer groups (based on geography and companysize).
§ An in-depth analysisof peptide platform and library service providers, featuring information ontheir company details, purpose of the platform, type of peptide manufacturedand platform access model.
§ Profiles of peptidesand macrocycle drug discovery service providers, featuring information on theyear of establishment, location of headquarters, peptide discovery service /platform portfolio, recent developments, and an informed future outlook.
§ An analysis of thepartnerships that have been established in the recent past, covering mergersand acquisitions, research collaborations, R&D agreements, licensingagreements (related to both technology platforms and service providers) andother form of collaborations.
§ An analysis of proprietarydisplay technologies developed by different drug discovery technologyproviders, based on the 2X2 matrix.
§ A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)
§ Type of peptides
§ Synthetic peptides
§ Biologic andrecombinant peptides
§ Type of discoverysteps
§ Target identificationand validation
§ Hit identification
§ Lead generation
§ Lead optimization
§ Therapeutic Area
§ Oncological disorders
§ Metabolic disorders
§ Cardiovasculardisorders
§ Infectious diseases
§ Urological disorders
§ Endocrine disorders
§ CNS disorders
§ Other diseases
§ Company Size
§ Small companies
§ Mid-sized companies
§ Large and very largecompanies
§ Key geographicalregions
§ Europe
§ North America
§ Asia-Pacific and theRest of the World
Key companies covered in the report
§ GenScript
§ JPT PeptideTechnologies
§ CPC Scientific
§ IRBM
§ Creative Peptides
§ Pepscan
§ Interprotein
§ RA Pharmaceuticals
§ Pepticom
§ PeptiDream
§ Creative Biolabs
§ MeSCue-Janusys
For more information pleaseclick on the following link:
https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Other RecentOfferings
1. DNA-Encoded Libraries: Platformsand Services Market, 2020–2030
2. Antibody ContractManufacturing Market, 2020 – 2030
3. Global AutoinjectorsMarket, 2020-2030
About Roots Analysis
Roots Analysis is oneof the fastest growing market research companies, sharing fresh and independentperspectives in the bio-pharmaceutical industry. The in-depth research,analysis and insights are driven by an experienced leadership team which hasgained many years of significant experience in this sector. If you’d like helpwith your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots AnalysisPrivate Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
